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Summary
Background Filaggrin is central to the pathogenesis of atopic dermatitis (AD). The
cheeks are a common initiation site of infantile AD. Regional and temporal
expression of levels of filaggrin degradation products [natural moisturizing fac-
tors (NMFs)], activities of filaggrin-processing enzymes [bleomycin hydrolase
(BH) and calpain-1 (C-1)] and plasmin, and corneocyte envelope (CE) maturity
in early life are largely unknown.
Objectives We conducted a cross-sectional, observational study investigating regio-
nal and age-dependent variations in NMF levels, activity of proteases and CE
maturity in stratum corneum (SC) from infants to determine whether these fac-
tors could explain the observed predilection sites for AD in early life.
Methods We measured NMF using a tape-stripping method at seven sites in the SC
of 129 children (aged < 12 months to 72 months) and in three sites in 56 neo-
nates and infants (< 48 h to 3 months). In 37 of these neonates and infants, cor-
neocyte size, maturity, BH, C-1 and plasmin activities were determined.
Results NMF levels are low at birth and increase with age. Cheek SC, compared
with elbow flexure and nasal tip, has the lowest NMF in the first year of life and
is the slowest to reach stable levels. Cheek corneocytes remain immature. Plas-
min, BH and C-1 activities are all elevated by 1 month of age in exposed cheek
skin, but not in elbow skin.
Conclusions Regional and temporal differences in NMF levels, CE maturity and pro-
tease activities may explain the predilection for AD to affect the cheeks initially and
are supportive of this site as key for allergen priming in early childhood. These
observations will help design early intervention and treatment strategies for AD.
What’s already known about this topic?
• Atopic dermatitis (AD) frequently starts in early infancy, and the first eczematous
lesions emerge on the cheeks.
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• Filaggrin is a major structural protein in the stratum corneum (SC).
• Filaggrin deficiency is associated with the development of AD and, in the context
of AD, food allergies and asthma.
• Filaggrin is metabolized into natural moisturizing factors (NMFs), which can be
measured in the SC.
What does this study add?
• Regional differences in NMF levels, corneocyte envelope immaturity and protease
activities may help explain why infantile AD most often initially affects the cheeks.
• Filaggrin processing, corneocyte maturity, and protease activities show regional
and temporal differences in infant skin.
• These findings may explain disease patterns in early-life AD.
What is the translational message?
• Cheek skin may be highly relevant for allergen priming.
• Emollient therapy at the vulnerable cheek site might help to prevent AD and/or
food sensitization.
Atopic dermatitis (AD) is the most common chronic inflam-
matory disease of childhood in the developed world.1 Clinical
manifestations of AD vary with age. In infancy, the first
lesions most commonly emerge on the cheeks and the scalp.2
A Danish study of 411 infants reported that AD lesions were
found to begin on the scalp, forehead, ear, neck and cheek in
infants, with the cheek being the most commonly involved
region.3 While infantile AD typically involves the facial skin,
the nasal tip is almost always lesion free (the ‘Yamamoto’
sign).4 These well-recognized predilection sites for AD suggest
distinct regional differences in skin structure and function.
Structural differences between infant and adult skin have
been reported.5,6 Infant corneocytes are smaller than those of
adults, correlating with a higher epidermal cell turnover rate
compared with adults.7 In contrast to adults, newborn babies
do not show variation in corneocyte size between nonacral
skin regions. Their corneocytes are uniformly small and are
similar in size to those found in the adult forehead.8 This sug-
gests consistently high epidermal turnover across the entire
skin surface in neonates. Adaptive changes, both in stratum
corneum (SC) water-handling properties and skin surface pH,
occur in early life. In full-term neonates, transepidermal water
loss (TEWL) data suggest a competent epidermal barrier func-
tion shortly after birth.5,9
A defective skin barrier is a key feature of AD.10 Filaggrin is
a major structural protein in the SC and its constituent amino
acids play a critical role in SC acidification and hydration.
Filaggrin deficiency is associated with impaired barrier func-
tion and the development of AD.11 Filaggrin deficiency in
children seems to define a specific endotype of AD, character-
ized by a predilection to exposed areas of the body, in partic-
ular the cheeks and hands.12 Profilaggrin, the phosphorylated
precursor to filaggrin, is expressed in the upper stratum gran-
ulosum, where processing is initiated. A complex cascade of
dephosphorylation and proteolysis liberates functionally active
filaggrin monomers that, within the SC, are further cleaved
into short peptides and are finally degraded fully to form a
cytoplasmic pool of hygroscopic amino acids and their deriva-
tives, known as natural moisturizing factor (NMF). Following
deimination of arginine residues, the cysteine/aspartic pro-
teases caspase-14, bleomycin hydrolase (BH) and calpain-1
(C-1), located mainly in the upper SC, have been shown to be
important in enzymatic degradation of filaggrin.13,14 C-1 is
also involved in the processing of profilaggrin to filaggrin,
and also in corneocyte maturation.15,16
NMF modulates the pH of the SC surface, promotes the
retention of water within the corneocytes and may exert
antimicrobial activity.1 Important amino acid derivatives
include trans-urocanic acid (t-UCA) and pyrrolidone carboxylic
acid (PCA).1 The enzyme histidase converts histidine (His) to
t-UCA.17 Glutamic acid is converted to PCA, by nonenzymatic
degradation (cyclization) in addition to enzymatic processes
and overall, constitutes 12% of NMF.18–20 In addition, non-
filaggrin-derived compounds such as lactate, urea, sugars and
ions contribute to NMF. The amino acids and their derivatives
that constitute NMF can be measured and closely correlate
with filaggrin content.21 The epidermis expresses several pro-
teases that are involved in a range of key epidermal responses,
including proliferation, differentiation, lipid barrier homeosta-
sis and tissue remodelling.22 Plasmin plays an important, but
still not completely defined role in the corneocyte maturation
process and is a marker for SC stress and inflammation, even
in areas lacking clinically observable inflammation.23
The reasons why AD has a predilection for certain body
sites and why the affected regions vary with age in childhood
remain unknown. Age-related and regional differences in skin
structure and function are likely important. Here, we investi-
gated the regional and temporal expression of filaggrin-
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derived NMF together with filaggrin-processing enzyme
activities (BH and C-1), corneocyte phenotypes and plasmin
activities in a large cohort of healthy neonates, infants and
children in anatomical locations relevant for AD.
Patients and methods
Study population
In phase I of the study, healthy infants and children were
recruited from March to September 2013. These infants and
children were scheduled to undergo elective surgical proce-
dures in Our Lady’s Children’s Hospital, Dublin, Ireland. Chil-
dren were recruited if they did not have a history suggestive
of AD or any other inflammatory skin disease. An experienced
paediatric dermatologist (M.A.McA.) examined all infants.
Other exclusion criteria from the study included infants and
children who had pyrexial illness in the preceding 2 weeks,
those who had received immunosuppressive systemic therapy,
such as oral corticosteroids, in the preceding 3 months, and
patients whose ancestry was not exclusively Irish (four of four
grandparents). Non-Irish children were excluded to allow for
accurate FLG mutation stratification. The following seven body
sites were tape stripped in phase I: cheek, nasal tip, nape of
neck, volar forearm at the elbow flexure, dorsal proximal
mid-upper limb, dorsal hand and the buttock.
Phase II of the study was carried out in The National
Maternity Hospital, Holles Street, Dublin, Ireland (from July
to September 2014). Infants were recruited, both in the
postnatal wards in the 48 h following delivery and in the
early weeks of life in outpatient/ambulatory clinics, when
attending for elective baby checks. Identical inclusion and
exclusion criteria for phase I were applied for phase II. The
following three body sites were tape stripped in this cohort:
cheek (C), nasal tip (T) and volar forearm at the elbow flex-
ure (E). The number of body sites sampled had to be reduced
in view of the very young age of these individuals. The three
body sites in this cohort were selected because preliminary
data from phase I of the study suggested that these body sites
were most likely to provide the greatest amount of informa-
tion. As this was an exploratory study, a definitive sample size
that would allow statistically significant findings was difficult
to predict. After phase I yielded significant results, we calcu-
lated that the smaller sample size would be informative in
phase II. The power analysis was based on the difference in
NMF values obtained between skin sites C, T and E. The high-
est sample size of n = 38 (power 80%; P = 005, paired
t-test) was obtained for the difference between C and E (mean
021 and SD 047). We included more children (n = 59) as
we expected that tape stripping might fail in neonates and
infants.
The study was conducted in accordance with the Declara-
tion of Helsinki principles and was approved by the Research
Ethics Committee of Our Lady’s Children’s Hospital, Dublin,
Ireland. Full written informed consent was obtained from the
parents of each individual.
Sampling of the stratum corneum by tape stripping
All sampled sites were emollient free for 24 h before tape stripping.
The SC was sampled using the method previously described.21 Cir-
cular adhesive tape strips (38 cm2, D-Squame, CuDerm, Dallas, TX,
U.S.A.) were attached to the skin and, in all regions apart from the
nasal tip, pressed for 10 s with a constant pressure (225 g cm2)
using a D-Squame pressure instrument D500 (CuDerm). On the
nasal tip, the circular adhesive tape strip was cut in half, placed on
the skin, and pressure was applied manually for 10 s.24 Eight consec-
utive tape strips were sampled, all from the same site. Tape strips
were stored at80 °C until analysis.
Filaggrin genotyping
All patients were screened for the nine most common FLG muta-
tions found in the Irish population (R501X, Y2092X, 2282del4,
R2447X, S3247X, R3419X, 3702X, S1040X and G1139X) from
DNA extracted from a blood sample or buccal swab. The methods
used have been previously described.25 All individuals that were
heterozygous or homozygous for loss-of-function mutations in
the FLG gene were excluded from the analysis.
Determination of filaggrin breakdown products in the
stratum corneum
NMF component analysis (His, PCA, trans-UCA and cis-UCA)
was performed and total SC protein determined on the fourth
consecutive tape stripping according to the method described in
detail elsewhere.21 The four components were combined to give
a ‘total NMF’ value. NMF components in the SC from each tape
stripping were extracted with 500 lL 25% (w/w) ammonia
solution. After evaporation of the ammonia extract, the residue
was reconstituted in 250 lL pure water and analysed by high-
performance liquid chromatography ultraviolet analysis. Owing
to incomplete extraction recovery of SC proteins by ammonia,
the second extraction of proteins from the tape stripping was
performed with 01 mol L1 KOH solution over 24 h. The pro-
teins were determined in both extracts by using Pierce Micro
BCA protein assay kit (Thermo Fisher Scientific, Rockford, IL,
U.S.A.). The levels of NMF components in the SC were normal-
ized for proteins and expressed as mmol NMF per g of protein.
Natural moisturizing factor depth profiling
To ensure that NMF measurement in different age groups and
sites was not affected by varying SC thickness, NMF profiling
was performed on consecutive tape strips in 13 individuals.
NMF was assessed in the second, sixth and eighth tape strip-
ping in participants from < 48 h to 3 months of age at the
cheek and elbow sites.
Stratum corneum maturation assays
The first tape stripping from 37 individuals at two skin sites,
i.e. the cheek and elbow, were investigated for corneocyte
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envelope (CE) maturity. This was performed using differential
Nile red and immunostaining for the late epidermal differenti-
ation marker involucrin, using a modification of the previ-
ously described method.26
Measurement of stratum corneum protease activities:
calpain-1 and bleomycin hydrolase and plasmin
The same 37 individuals were assessed for plasmin, C-1
and BH activities. Protease activities were determined on
the fifth tape stripping using previously reported
methods.23,26–29
Statistical analysis
All calculations were performed using Prism 6 software
(GraphPad, San Diego, CA, U.S.A.). The distribution of data
was tested using the Shapiro–Wilk normality test. The applied
statistical test is indicated in the figure legends.
Results
Demographic data of participants
In total, 188 infants and children were recruited; 112 were
male and 76 were female (Table 1). The average age, age
range and age groups are outlined in Tables 1 and 2. The
demographic characteristics of the 37 participants for whom
corneocyte maturity assays were performed and measurements
of C-1, BH and plasmin were taken are outlined in Table S1
(see Supporting Information). FLG mutation status was deter-
mined for all participants in phase I. In phase II we were
unable to establish the FLG status definitively in 12 participants
because of poor DNA quality obtained from this subset of
buccal swabs (Table S2; see Supporting Information). These
were excluded from analysis.
Total natural moisturizing factor is low after birth,
increases rapidly in postnatal life and is regionally
determined, with the cheek skin being slow to mature
In the first 48 h after birth, the total NMF levels were low
in all sampled regions. There was an increase in the total
NMF levels in the early weeks of life in all regions. The
nasal tip and the elbow flexure had a rapid increase in total
NMF levels in the first 4 weeks of life, after which NMF
stabilizes, with no further increase (Fig. 1). In contrast, in
cheek skin there was still a significant increase (P < 0001,
Mann–Whitney two-sided paired test) in NMF between the
time periods of 1–11 months and 12–35 months. Further-
more, the rate of increase in levels of NMF in cheek SC
was much slower (Fig. S1; see Supporting Information),
and there was a significant (r2 = 028, P < 0001) linear
response of NMF vs. age from 1 month up to 72 months
(Fig. S1; see Supporting Information). Of note, there was
no variation in NMF levels with SC depth after 48 h of age
(Fig. S2; see Supporting Information). NMF levels on the
remaining body sites sampled in phase I (nape of neck,
dorsal hand, dorsal upper limb and buttock) were stable
from 1 month to 72 months of age (Fig. S3; see Supporting
Information). In the first year of life, the NMF values for
the cheek SC were significantly lower compared with those
of the elbow (median of difference 015; P < 0001, Wil-
coxon paired t-test), although this difference was not signif-
icant at ages > 12 months (Fig. S4; see Supporting
Information).
The histidine/urocanic acid ratio and the trans-urocanic
acid/cis-urocanic acid ratio change rapidly postnatally
and transition to a steady state more quickly in exposed
skin sites compared with nonexposed sites
The His/UCA ratio rapidly increases in the first 3 months
of life in exposed sites, and reaches a steady state from
4 months of age onwards (approximately twofold to three-
fold). In the nonexposed elbow flexure skin the His/UCA
ratio remains low for the first 3 months of life (Fig. 2).
The cis-UCA/total UCA ratio increases rapidly in postnatal
life in exposed sites. The ratio of cis-UCA to the total
amount of UCA (cis + trans isomer) in the cheek and nasal
tip skin reaches the levels 30–50% around the first year of
life while the ratio between cis-UCA/total UCA in the elbow
flexure SC remains low (Fig. 3).
Table 1 Age groups and sex of all recruited participants
N Male Female Mean age Age range
Phase I 129 78 51 279 months 025–70
months
Phase II 59 34 25 205 days 1–84 days
Total 188 112 76
Table 2 Sex distribution, mean age and age range of all participants in phase I and phase II of study
Age groups < 48 h 48 h to 4 weeks 1–3 months 4–11 months 12–36 months 36–72 months
Male, n 13 12 17 14 28 27
Female, n 13 8 9 14 16 16
Total 26 20 26 28 44 43
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Bleomycin hydrolase and calpain-1 activities increase
after 1 month of life and are higher in the cheek than
the elbow
The late-stage filaggrin-processing enzymes, BH and C-1 activ-
ities are similar in the cheek and elbow skin after birth. After
1 month of age the levels increase significantly in the exposed
cheek skin, but not at the elbow (Figs 4 and S5; see Support-
ing Information).
Plasmin activity increases at 1 month of age in the cheek
and correlates with trans-urocanic acid/cis-urocanic acid
ratio in cheek skin
Plasmin activities are higher in the cheek compared with
the elbow at birth (Fig. 4). At 1 month, the plasmin activ-
ity generally increases in the exposed cheek skin. Plasmin
activities correlate with trans-UCA/cis-UCA ratios at the cheek
(Fig. 5).
Fig 1. Levels of total natural moisturizing factor (NMF), histidine (His), pyrrolidone carboxylic acid (PCA) and sum of trans-urocanic acid (UCA)
and cis-UCA in the stratum corneum of children (median with interquartile range) in different age groups [< 48 h (n = 18), 48 h – 4 weeks
(n = 18), 1–11 months (n = 41), 12–35 months (n = 25) and 36–72 months (n = 30)] on three body regions. Differences between age groups
were determined by Kruskal–Wallis test followed by Dunn’s multiple comparisons test. ***P < 0.001, **P < 0.01 and *P < 0.05.
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Fig 2. Ratio of histidine (His) to urocanic acid (UCA) (median with interquartile range) (a–c) and linear regression between ratio of His to UCA
and age of children [(d–f) up to 3 months of age; (g–i) from 3 to 72 months of age] on three body regions. For regression analysis the values
were log-transformed. Age groups: < 48 h (n = 18), 48 h – 4 weeks (n = 18), 1–3 months (n = 21), 4–11 months (n = 20), 12–35 months
(n = 25), 36–72 months (n = 30). ***P < 0.001, **P < 0.01 and *P < 0.05 as determined by Kruskal–Wallis test followed by Dunn’s multiple
comparisons test. b, slope of the regression line; CI, confidence interval.
(a) (b) (c)
Fig 3. Ratio of cis-urocanic acid (UCA) to total UCA (cis-UCA + trans-UCA) (median with interquartile range). Age groups: < 48 h (n = 18), 48 h
– 4 weeks (n = 18), 1–3 months (n = 21), 4–11 months (n = 20), 12–23 months (n = 1), 24–35 months (n = 14), 36–47 months (n = 12)
and 48–72 months (n = 18). Differences between age groups were determined by Kruskal–Wallis test followed by Dunn’s multiple comparisons
test. ***P < 0.001, **P < 0.01 and *P < 0.05.
© 2018 The Authors British Journal of Dermatology
published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists
British Journal of Dermatology (2018) 179, pp431–441
436 Stratum corneum in early life, M.A. McAleer et al.
Cheek corneocytes have a more immature phenotype in
contrast with elbow corneocytes
The cheek corneocytes have an immature phenotype from
birth, which does not change with age. This contrasts with
the elbow corneocytes, which have a mature phenotype from
birth (Fig. 4). In keeping with an immature phenotype, the
cheek corneocytes had higher cohesion – specifically, less SC
protein was removed, which meant that the corneocytes were
more tightly cohesive (Fig. 6).
Discussion
Our results show that NMF is low at birth at all investigated
skin sites and increases significantly over the first month of
life, suggesting that the SC rapidly adapts to the dramatic envi-
ronmental shift from in utero to ex utero. Our findings are in
keeping with a previous study that measured free amino acids
in the chest or back skin of 30 neonates and infants.30 Simi-
larly, Chittock et al. reported low NMF in the skin of 115 neo-
nates at birth, with a significant increase in NMF by 4 weeks
of age.31 Low NMF in infant skin at birth is in keeping with
reports in variations between neonatal and adult rat skin. Scott
and Harding reported that during late fetal development filag-
grin accumulates throughout the entire thickness of rat SC and
immediately after birth filaggrin proteolysis occurs in the
outer SC.32
We found that the cheek skin was a unique site with
respect to NMF levels and corneocyte maturity in infancy.
NMF levels in cheek SC were much slower to increase com-
pared with other sites, including exposed sites such as the
nasal tip (Fig. 7). Furthermore, in the first year of life the
cheek NMF levels were significantly lower than the corre-
sponding levels in the elbow SC. The cheek is frequently the
site of initial inflammation in infantile AD. Absolute low levels
of NMF and a slow increase in NMF levels may play a role in
(a) (b) (c)
(d) (e) (f)
Fig 4. (a–c) Corneocyte envelope (CE) maturity, stratum corneum (SC) cohesion, cornecyte surface area and activity of (d–f) bleomycin hydrolase
(BH), calpain-1 (C-1) and plasmin in the SC of children up to 11 months of age (n = 37). Difference between cheek region and elbow flexure
region were determined by two-tailed paired t-test (SC cohesion and CE maturity) or by two-tailed Wilcoxon matched-pairs signed-rank test
(corneocyte surface area, BH, C-1 and plasmin). ****P < 0.0001, **P < 0.01.
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disease initiation at this site, as may high plasmin activity. The
elbow flexure was notable for reaching a steady state of NMF
early in infancy. This site is not typically involved in infantile
eczema, but is a classic site of childhood AD. The reason why
this site is vulnerable in childhood AD is unclear, but may
reflect the local microbiome rather than NMF levels. It has
been shown that age strongly affects the microbiome in
infants, with bacterial community structure and diversity shift-
ing over time.33 Furthermore, compared with exposed skin
sites, elbow flexure skin had a consistently lower ratio of cis-
UCA to total UCA. Cis-UCA has previously been suggested as
an immunosuppressant.34
We also report other important insights into postnatal SC
biology. In early postnatal life, there is a rapid increase in the
ratio between His and its metabolite UCA (Fig. 2), which
levels off after approximately 3 months. This might be caused
by the differences related to age and skin site in the expres-
sion and activity of histidase, which has an optimum pH of
about 85 and decreases towards a lower pH.35 The pH of the
skin surface is highest in the first 2 weeks after birth (pH =
60) and gradually decreases with age.36
To provide a more comprehensive definition of the gener-
ation of NMF in the SC in early postnatal life, along with SC
stress, we measured the activities of SC proteases BH and
C-1 and plasmin at the cheek and elbow sites in a selection
of participants. The active forms of BH and C-1 are critical
in the final stages of filaggrin degradation.14–16,37–39 We
demonstrated increased activity of BH in the exposed cheek
skin after 1 month of life. In contrast, levels at the elbow
remained unchanged with increasing age. At birth plasmin
activities, which indicate SC stress and impaired barrier func-
tion, are high in the cheek compared with the elbow. At
1 month of age plasmin activities increase in the exposed
cheek skin, but not at the elbow. Furthermore, plasmin
activity correlated with the cis-UCA/total UCA ratio in the
cheek skin, but not at the elbow. Raj et al. hypothesized that
these atmospheric conditions result in a feedback mechanism
to upregulate filaggrin degradation proteases, thereby produc-
ing NMF in an effort to improve barrier function and/or
epidermal water retention.29 Our data support this hypothe-
sis, in addition to demonstrating that it is relevant in infant
skin during early postnatal life.
CE maturity is critical for skin barrier function. We show
that the cheek CE is immature from birth and does not
improve rapidly with age. Therefore, cheek CE immaturity is
present from birth and persists into adulthood.29,40,41 In
adults, facial TEWL is much higher than that of the forearm
and upper arm.42 It is notable that the facial skin, unlike most
other body sites, is continually exposed to environmental
stress. The nasal tip is a site of interest in this study; while this
site matures rapidly to steady-state NMF levels, these levels
settle at relatively low levels, suggesting that at this site factors
other than NMF or filaggrin expression protect against the
development of AD. At this site sebum production is much
higher, as is skin hydration, which are factors that may offset
low NMF.
Furthermore, low NMF and low maturity of the CE in the
infant cheek SC may be important for allergen sensitization at
this site, and subsequent food allergy. There is clear evidence
that epicutaneous exposure to peanut through an impaired
skin barrier increases the risk of peanut sensitization and con-
firmed peanut allergy.43–45 Early-life exposure to peanut anti-
gen in household dust is a risk factor for peanut sensitization
and allergy in children46 and murine models support the
concept of an impaired skin barrier as a route for sensitiza-
tion.43–45,47 The demonstration of low NMF levels, a more
inflammatory plasmin profile and decreased corneocyte matu-
rity in the exposed cheek skin of infants supports the hypothe-
sis of this site being key to food sensitization and allergy in
early life, either independently or in the setting of AD. Saliva
and food protein exposure causing irritation at this site are
likely cofactors in this pathology.
The early postnatal weeks are particularly dynamic for SC
maturation. The infant cheek SC has delayed NMF
Fig 5. Linear regression plasmin activity vs. ratio of cis-urocanic acid (UCA) to total UCA (cis-UCA + trans-UCA) on two body sites. The values
were log-transformed. b, slope of the regression line; CI, confidence interval.
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normalization, higher cohesion and reduced CE maturation,
and shows evidence of increased SC stress from birth. We pro-
pose that this combination of factors facilitates the initiation
of AD inflammation and allergic sensitization. Our results sup-
port the concept of improving SC moisturization and skin
barrier function in sites of vulnerability in infants in an effort
to prevent the onset of AD.48,49 The use of moisturizers may
compensate for the decrease in NMF levels. Even small
increases in filaggrin copy number that drive NMF have been
shown to be protective against developing AD.50
Fig 6. Corneocyte envelope (CE) maturity, stratum corneum (SC) cohesion and cornecyte surface area in the SC of children (median with
interquartile range) in three age groups across two body regions. Age groups: < 48 h (n = 10); 48 h – 4 weeks (n = 10) and 1–11 months
(n = 16). Differences between age groups were determined by one-way ANOVA followed by Tukey’s multiple comparison test (for CE maturity and
cornecyte surface area on cheek region Kruskal–Wallis test followed by Dunn’s multiple comparisons test was used). *P < 0.05.
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In summary, regional SC biochemical and cellular character-
istics may explain the initial clinical patterns of AD in infancy.
Cheek SC early in life is likely permissive for the development
of AD, allergen penetration and food allergy.
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